Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iSpecimen (ISPC) Cash from Financing Activities (2020 - 2025)

iSpecimen has reported Cash from Financing Activities over the past 6 years, most recently at $5.0 million for Q4 2025.

  • Quarterly results put Cash from Financing Activities at $5.0 million for Q4 2025, up 32.94% from a year ago — trailing twelve months through Dec 2025 was $14.9 million (up 155.66% YoY), and the annual figure for FY2025 was $10.2 million, up 76.04%.
  • Cash from Financing Activities for Q4 2025 was $5.0 million at iSpecimen, down from $5.2 million in the prior quarter.
  • Over the last five years, Cash from Financing Activities for ISPC hit a ceiling of $19.6 million in Q4 2021 and a floor of -$3.5 million in Q4 2022.
  • Median Cash from Financing Activities over the past 5 years was $467628.5 (2022), compared with a mean of $2.5 million.
  • Peak annual rise in Cash from Financing Activities hit 41304.5% in 2024, while the deepest fall reached 275.47% in 2024.
  • iSpecimen's Cash from Financing Activities stood at $19.6 million in 2021, then crashed by 117.88% to -$3.5 million in 2022, then soared by 100.09% to $3153.0 in 2023, then surged by 119541.45% to $3.8 million in 2024, then soared by 32.94% to $5.0 million in 2025.
  • The last three reported values for Cash from Financing Activities were $5.0 million (Q4 2025), $5.2 million (Q3 2025), and $3.8 million (Q4 2024) per Business Quant data.